Latest News and Press Releases

Myriad Genetics announced today the appointment of Brian Donnelly as chief commercial officer (CCO), effective May 1, 2025.

SALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven studies...

New York, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The Molecular Diagnostics Market is experiencing robust growth due to technological advancements and increasing demand for personalized medicine. Key...

Burlingame, Nov. 07, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global genomic cancer testing market is estimated to be valued at US$ 16.15 billion in 2022 and is expected to...

Fort Myers, Fla., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) celebrated the addition of genomic testing capabilities at its Next Generation...

New York, United States, Aug. 16, 2022 (GLOBE NEWSWIRE) -- The term "NGS," for "high throughput sequencing," describes a wide range of cutting-edge sequencing methods. Researchers can study...

WASHINGTON, March 11, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Heart Failure POC & LOC Devices Market finds that factors such as, increasing geriatric...

Garden City, NY, Sept. 08, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, today announced that its Board of Directors has authorized the...

Farmington, Conn., Nov. 05, 2020 (GLOBE NEWSWIRE) -- More than 157 million people in the U.S. receive their healthcare insurance through employer health plans. One potential means of enhancing...

San Diego, CA, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Biotheranostics announces the publication of results from the IDEAL study in Clinical Cancer Research which reports novel findings of the Breast...